Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 32,948 shares were traded during trading, an increase of 383% from the previous session's volume of 6,825 shares.The stock last traded at $77.65 and had previously closed at $76.41.
Wall Street Analyst Weigh In
ERFSF has been the subject of several research reports. Citigroup reissued a "neutral" rating on shares of Eurofins Scient in a report on Monday, February 2nd. BNP Paribas Exane upgraded Eurofins Scient to an "outperform" rating in a research note on Monday, January 5th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold".
Read Our Latest Research Report on Eurofins Scient
Eurofins Scient Stock Performance
The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. The company's 50 day simple moving average is $79.99 and its 200-day simple moving average is $74.96.
About Eurofins Scient
(
Get Free Report)
Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.
Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Eurofins Scient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.
While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.